SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M.B. Faries, A.J. Cochran, R.M. Elashoff, J.F. Thompson, Multicenter Selective Lymphadenectomy Trial-I confirms the central role of sentinel node biopsy in contemporary melanoma management, British Journal of Dermatology, 2015, 172, 3
  2. 2
    M. Sladden, S. Zagarella, C. Popescu, M. Bigby, No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report, British Journal of Dermatology, 2015, 172, 3
  3. 3
    Huazhen Lin, Yi Li, Liang Jiang, Gang Li, A semiparametric linear transformation model to estimate causal effects for survival data, Canadian Journal of Statistics, 2014, 42, 1
  4. 4
    Manisha Desai, Karen S. Pieper, Ken Mahaffey, Challenges and Solutions to Pre- and Post-Randomization Subgroup Analyses, Current Cardiology Reports, 2014, 16, 10

    CrossRef

  5. 5
    Donald L. Morton, John F. Thompson, Alistair J. Cochran, Nicola Mozzillo, Omgo E. Nieweg, Daniel F. Roses, Harold J. Hoekstra, Constantine P. Karakousis, Christopher A. Puleo, Brendon J. Coventry, Mohammed Kashani-Sabet, B. Mark Smithers, Eberhard Paul, William G. Kraybill, J. Gregory McKinnon, He-Jing Wang, Robert Elashoff, Mark B. Faries, Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma, New England Journal of Medicine, 2014, 370, 7, 599

    CrossRef

  6. 6
    Alexander C. J. van Akkooi, Alexander M. M. Eggermont, Melanoma: MSLT-1—SNB is a biomarker, not a therapeutic intervention, Nature Reviews Clinical Oncology, 2014, 11, 5, 248

    CrossRef

  7. 7
    Mark B. Faries, Alistair J. Cochran, John F. Thompson, MSLT-I—response of clinical trial investigators, Nature Reviews Clinical Oncology, 2014, 11, 11, 680

    CrossRef

  8. 8
    John F. Thompson, Mark B. Faries, Alistair J. Cochran, Sentinel Lymph Node Biopsy for Melanoma: A Plea to Let the Data be Heard, Annals of Surgical Oncology, 2014, 21, 11, 3362

    CrossRef

  9. 9
    Daniel Coit, Sentinel Lymph Node Biopsy for Melanoma: A Plea to Let the Data Speak, Annals of Surgical Oncology, 2014, 21, 11, 3359

    CrossRef

  10. 10
    Alexander C.J. van Akkooi, Sentinel node followed by completion lymph node dissection versus nodal observation, Melanoma Research, 2014, 24, 4, 291

    CrossRef

  11. 11
    Alexander C. J. van Akkooi, Alexander M. M. Eggermont, SLNB in melanoma—DFS a true and cost-effective benefit?, Nature Reviews Clinical Oncology, 2014, 11, 11, 680

    CrossRef

  12. 12
    Athanassios Kyrgidis, Thrasivoulos Tzellos, Simone Mocellin, Zoe Apalla, Aimilios Lallas, Pierluigi Pilati, Alexander Stratigos, Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma, The Cochrane Library,